<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JVMS</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Veterinary Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0916-7250</issn>
      <issn pub-type="epub">1347-7439</issn>
      <publisher>
        <publisher-name>The Japanese Society of Veterinary Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25947561</article-id>
      <article-id pub-id-type="pmc">4591165</article-id>
      <article-id pub-id-type="publisher-id">14-0454</article-id>
      <article-id pub-id-type="doi">10.1292/jvms.14-0454</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Internal Medicine</subject>
          <subj-group>
            <subject>Note</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The first case of feline sinonasal aspergillosis due to <italic>Aspergillus
fischeri</italic> in Japan</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>KANO</surname>
            <given-names>Rui</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>TAKAHASHI</surname>
            <given-names>Tomoko</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>HAYAKAWA</surname>
            <given-names>Takeshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>YAMAYA</surname>
            <given-names>Yoshiki</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>HASEGAWA</surname>
            <given-names>Atsuhiko</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KAMATA</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1)</label>Veterinary Pathobiology, Nihon University College of
Bioresource Sciences, 1866 Kameino, Fujisawa, Kanagawa 252&#x2013;0880, Japan</aff>
        <aff id="aff2"><label>2)</label>Veterinary Radiology, Nihon University College of
Bioresource Sciences, 1866 Kameino, Fujisawa, Kanagawa 252&#x2013;0880, Japan</aff>
        <aff id="aff3"><label>3)</label>Division of Veterinary Respiratory Medicine, Animal Medical
Center, Nihon University College of Bioresource Sciences, Kameino, Fujisawa, Kanagawa
252&#x2013;0880, Japan</aff>
        <aff id="aff4"><label>4)</label>Teikyo University Institute of Medical Mycology, 539 Otsuka,
Hachioji, Tokyo 192&#x2013;0395, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Kano, R., Veterinary Pathobiology,
Nihon University College of Bioresource Sciences, 1866 Kameino, Fujisawa, Kanagawa
252&#x2013;0880, Japan. e-mail: kanou.rui@ nihon-u.ac.jp</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <volume>77</volume>
      <issue>9</issue>
      <fpage>1183</fpage>
      <lpage>1185</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>9</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2015 The Japanese Society of Veterinary Science</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Feline upper respiratory tract infection due to <italic>Aspergillus</italic> spp. is
considered an emerging disease, with the number of reported cases continuing to rise. In
this study, we report the first case of feline sinonasal aspergillosis caused by
<italic>Aspergillus fischeri</italic> in Japan. The patient presented after 2 months of
progressive facial deformity around the nose and nasal discharge. The isolate from this
case was susceptible to itraconazole (ITZ), voriconazole and micafungin, but was resistant
to amphotericine B. However, the infected cat died approximately 1 month after referral,
despite treatment for 12 days ITZ administered orally at 10 mg/kg.</p>
      </abstract>
      <kwd-group>
        <kwd>
          <italic>Aspergillus fischeri</italic>
        </kwd>
        <kwd>feline</kwd>
        <kwd>molecular identification</kwd>
        <kwd>sinonasal aspergillosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Feline upper respiratory tract (URT) infection due to <italic>Aspergillus</italic> spp. is
considered an emerging disease, with the number of reported cases continuing to rise [<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>].
<italic>Aspergillus fumigatus</italic> has been the most frequently reported etiologic agent
of sino-orbital aspergillosis in cats [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r7" ref-type="bibr">7</xref>]; two other <italic>Aspergillus</italic> species,
<italic>A. udagawae</italic> and <italic>A. fischeri,</italic> have also been implicated.
The minimum inhibitory concentrations (MICs) of amphotericin B (AMB) and azoles [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref>] are elevated for <italic>A. udagawae</italic> and
<italic>A. fischeri</italic> compared with <italic>A. fumigatus</italic>, but distinguishing
<italic>A. udagawae</italic> and <italic>A. fischeri</italic> from <italic>A.
fumigatus</italic> requires molecular analyses. Some reports described that the feline
infections due to <italic>A. udagawae</italic> and <italic>A. fischeri</italic> do not respond
to treatment with AMB, itraconazole (ITZ) or micafungin (MCF) [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref>]. These results suggest that speciation and antifungal susceptibility testing of
infecting agents are important to ensure effective treatment of feline URT aspergillosis. In
this study, we report the first Japanese feline case of sinonasal aspergillosis caused by
<italic>A. fischeri</italic>.</p>
    <p><italic>Case</italic>: A castrated Russian blue cat (11 years old; weight, 2.9 kg) was
referred to the Nihon University Animal Medical Center, Kanagawa, Japan, in June 2014 after
exhibited progressive facial deformity around the nose with nasal discharge over the previous
2 months. The cat suffered from diabetes mellitus and had been treated with insulin for 5
years. However, control by insulin injection was not succeesful in the patient cat. Physical
examination of the cat showed swelling on the nose (<xref ref-type="fig" rid="fig_001">Fig.
1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Pus discharge and an ulcer were observed on the mass on the left side of the bridge of
the nose.</p></caption><graphic xlink:href="jvms-77-1183-g001"/></fig>), depression and weight loss. The results of hematological examination, a serum
biochemistry panel and urinalysis are shown in <xref rid="tbl_001" ref-type="table">Table
1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Hematological examination, serum biochemistry panel and urinalysis of the patient
cat</title></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">Ht</td><td align="left" rowspan="1" colspan="1">23%</td><td align="left" rowspan="1" colspan="1">ALB</td><td align="left" rowspan="1" colspan="1">42 U/<italic>l</italic></td><td align="left" rowspan="1" colspan="1">Na</td><td align="left" rowspan="1" colspan="1">152 mEq/<italic>l</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Hb</td><td align="left" rowspan="1" colspan="1">7.3 g/d<italic>l</italic></td><td align="left" rowspan="1" colspan="1">ALP</td><td align="left" rowspan="1" colspan="1">31 U/<italic>l</italic></td><td align="left" rowspan="1" colspan="1">K</td><td align="left" rowspan="1" colspan="1">2.7 mEq/<italic>l</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">PLT</td><td align="left" rowspan="1" colspan="1">772 &#xD7; 10<sup>3</sup>/<italic>&#xB5;l</italic></td><td align="left" rowspan="1" colspan="1">ALT</td><td align="left" rowspan="1" colspan="1">29 U/<italic>l</italic></td><td align="left" rowspan="1" colspan="1">Cl</td><td align="left" rowspan="1" colspan="1">110 mEq/<italic>l</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">WBC</td><td align="left" rowspan="1" colspan="1">17,900/<italic>&#xB5;l</italic></td><td align="left" rowspan="1" colspan="1">AST</td><td align="left" rowspan="1" colspan="1">10 U/<italic>l</italic></td><td align="left" colspan="2" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Stab</td><td align="left" rowspan="1" colspan="1">0/<italic>&#xB5;l</italic></td><td align="left" rowspan="1" colspan="1">BUN</td><td align="left" rowspan="1" colspan="1">42 mg/d<italic>l</italic></td><td align="center" colspan="2" rowspan="1">Urine gravity 1.034</td></tr><tr><td align="left" rowspan="1" colspan="1">Seg</td><td align="left" rowspan="1" colspan="1">12,440/<italic>&#xB5;l</italic></td><td align="left" rowspan="1" colspan="1">CRE</td><td align="left" rowspan="1" colspan="1">0.8 mg/d<italic>l</italic></td><td align="center" colspan="2" rowspan="1">Glycosuria 2,000 mgl</td></tr><tr><td align="left" rowspan="1" colspan="1">Lym</td><td align="left" rowspan="1" colspan="1">1,969/<italic>&#xB5;l</italic></td><td align="left" rowspan="1" colspan="1">TCHOL</td><td align="left" rowspan="1" colspan="1">380 mg/d<italic>l</italic></td><td align="left" colspan="2" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mon</td><td align="left" rowspan="1" colspan="1">1,790/<italic>&#xB5;l</italic></td><td align="left" rowspan="1" colspan="1">GLU</td><td align="left" rowspan="1" colspan="1">316 mg/d<italic>l</italic></td><td align="left" colspan="2" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Eos</td><td align="left" rowspan="1" colspan="1">1,700/<italic>&#xB5;l</italic></td><td align="left" rowspan="1" colspan="1">Ca</td><td align="left" rowspan="1" colspan="1">10.8 mg/d<italic>l</italic></td><td align="left" colspan="2" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Baso</td><td align="left" rowspan="1" colspan="1">0/<italic>&#xB5;l</italic></td><td align="left" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1">2.3 mg/d<italic>l</italic></td><td align="left" colspan="2" rowspan="1"/></tr></tbody></table></table-wrap>. The cat was positive for the serum <italic>Aspergillus</italic> galactomannan
antigen (Health Sciences Research Institute, Inc., Yokohama, Japan). CT scan revealed a
soft-tissue mass within the right nasal cavity (<xref ref-type="fig" rid="fig_002">Fig. 2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>The left panel shows a computed tomographic (CT) image after administration of a
contrast agent at the level of the canine teeth. The animal&#x2019;s right nasal cavity (R)
is occupied by a large mass (*) that lacks contrast enhancement. The right panel shows
a reconstructed image from multiple CT images of the head; the right side of the nasal
bone is largely destroyed.</p></caption><graphic xlink:href="jvms-77-1183-g002"/></fig>). A chest and abdominal CT scan did not detect typical
<italic>Aspergillus</italic> infection signs. Histopathologic examination of biopsy samples
from this mass revealed granulomatous inflammation containing many branching hyphal filaments
(<xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>Histopathologic examination of the mass from the right nasal cavity of the case
revealed chronic purulent inflammation with many branching hyphal filaments (HE
stain).</p></caption><graphic xlink:href="jvms-77-1183-g003"/></fig>). A sample of nasal discharge was inoculated on Sabouraud&#x2019;s dextrose agar (SDA) and
incubated at 28&#xB0;C. Velvety-grayish white colonies developed within 2 weeks. Based on gross and
microscopic characteristics, the isolate was identified as an <italic>Aspergillus</italic>
species, and the case was diagnosed as sinonasal aspergillosis.</p>
    <p>ITZ (Janssen Pharmaceutical K.K., Tokyo, Japan) was administered orally at 10 mg/kg, once
daily for 12 days. In addition, antifungal susceptibility tests were initiated for the
infecting organism, and plans were made to flush the nasal airway with appropriate antifungal
solutions based on the results of these tests. However, the owner declined the use of topical
antifungal therapy pending the results of susceptibility testing because of the nasal airway
needs to be performed in an anesthetized condition that is a high risk for the patient. The
owner desired an effective and safe treatment.</p>
    <p>In the meantime, the case continued to deteriorate, and the cat died on day 19, i.e., one
week after completion of the ITZ regimen (and 28 days after the initial referral). Necropsy
was not performed.</p>
    <p><italic>Molecular identification of fungal species</italic>: Isolation of genomic DNA of the
isolate was reported previously [<xref rid="r9" ref-type="bibr">9</xref>].</p>
    <p>The internal transcribed spacer (ITS) region of the isolated <italic>Aspergillus</italic> was
amplified using the universal fungal primers ITS5 (5&#x2032; GGAAGTAAAAGTCGTAACAAGC) and ITS4 (5&#x2032;
TCCTCCGCTTATTGATAGC) [<xref rid="r2" ref-type="bibr">2</xref>]. PCR amplification and sequence
analyses were performed as described previously [<xref rid="r2" ref-type="bibr">2</xref>].</p>
    <p>Comparative sequence analyses by nucleotide BLAST analysis on the National Center for
Biotechnology Information (NCBI) website showed that the sequence of the ITS region amplified
from the isolate from the case was 100% identical to that of <italic>A. fischeri
</italic>(teleomorph of <italic>Neosartorya fischeri</italic>; GenBank accession no.
FJ624264).</p>
    <p>The sequences determined in this study have been deposited in GenBank (<italic>Aspergillus
fischeri</italic> genes for ITS1, 5.8S rRNA, ITS2, 28S rRNA, partial sequences, strain:
NUBS14001 clinical isolate from feline sinonasal aspergillosis; DDBJ accession number,
LC011422).</p>
    <p><italic>Testing of in vitro susceptibility to antifungal drugs</italic>: The <italic>in
vitro</italic> susceptibilities of the isolate to the antifungal drugs AMB, ITZ,
voriconazole (VRZ) and micafungin (MCF) were assessed by the E-test method [<xref rid="r11" ref-type="bibr">11</xref>]. The drug susceptibility tests for this isolate
revealed that the MICs of AMB, ITZ, VRZ and MCF by E-test were more than 32
mg/<italic>l,</italic> 0.25 mg/<italic>l</italic>, 0.064 mg/<italic>l</italic> and 0.012
mg/<italic>l</italic>, respectively.</p>
    <p>This work represents the first reported Japanese case of feline sinonasal aspergillosis due
to <italic>A. fischeri.</italic> In summarizing 22 cases of feline sinonasal aspergillosis in
Australia, Barrs <italic>et al.</italic> reported that the fungal pathogens were <italic>A.
fumigates</italic> (n=4), <italic>Neosartorya fischeri</italic> (n=1), <italic>A.
lentulus</italic> (n=1) or other <italic>Neosartorya</italic> spp. (n=16) [<xref rid="r4" ref-type="bibr">4</xref>]. Therefore, non-<italic>fumigatus</italic> aspergilli,
including <italic>A. fischeri</italic>, should be considered potential fungal pathogens in
feline URT aspergillosis.</p>
    <p><italic>A. fischeri</italic> is known as a causative agent of human respiratory aspergillosis
[<xref rid="r1" ref-type="bibr">1</xref>], but it has not been well investigated with regard
to susceptibility to AMB and azoles. The isolate from this case was susceptible to ITZ, VRZ
and MCF, but was resistant to AMB. Cant&#xF3;n <italic>et al</italic>. suggested that the
<italic>in vitro</italic> breakpoints (resistance) for AMB and azoles of
<italic>Aspergillus</italic> spp. were MICs &#x2265;4 mg/<italic>l</italic> [<xref rid="r6" ref-type="bibr">6</xref>].</p>
    <p>AMB is frequently selected for treatment of canine and feline cases of aspergillosis,
including feline URT aspergillosis [<xref rid="r10" ref-type="bibr">10</xref>]. Therefore, the
decision-making process for determining the therapy for therapy of feline URT aspergillosis
should include determination of the MICs of other antifungal drugs.</p>
    <p>We administered oral ITZ to the patient cat, but could not confirm the efficacy of this
treatment due to subsequent mortality. The poor response in this case may have reflected
progression of the infection. In addition, the pathogenesis of diabetes mellitus might
interfere with ITZ therapy and has been recognized as a risk factor in feline URT
aspergillosis [<xref rid="r5" ref-type="bibr">5</xref>]. More aggressive management using
intravenous administration or nasal air way flushing with ITZ solution may have been
needed.</p>
    <p>This case was diagnosed as aspergillosis by a serum <italic>Aspergillus</italic>
galactomannan antigen test as well as histopathologic examination and mycological
identification. The antigen test has been reported to have poor specificity, but moderate
sensitivity as a noninvasive screening test to rule out infection in feline patients with
suspected URT aspergillosis [<xref rid="r12" ref-type="bibr">12</xref>]. Therefore, the test
should be evaluated for rapid, noninvasive screening of feline URT aspergillosis, including
<italic>A. fischeri</italic> infection.</p>
    <p>The low susceptibility to antifungals seen in isolates of non-<italic>fumigatus</italic>
aspergilli indicates that molecular identification of <italic>Aspergillus</italic> species and
<italic>in vitro</italic> susceptibility testing are needed in the selection of effective
antifungal drugs and prediction of the prognosis of feline URT aspergillosis. Further studies
are required to determine the distinct resistance profiles of infecting
non-<italic>fumigatus</italic> aspergilli, since antifungal susceptibility may be a major
determinant of treatment outcome. Aspergillosis is generally an opportunistic infection, and
host immunocompetence is thought to be an important determinant in the development of the
infection. The frequency of use of chemotherapy and immunosuppressive drugs is increasing in
the veterinary field. Due to the risk of opportunistic fungal infections should exercise care
when they use these drugs.</p>
    <p>In conclusion, feline URT infection due to <italic>Aspergillus</italic> spp. is considered an
emerging disease, with the number of reported cases continuing to rise. To our knowledge, this
was the first feline case of sinosal aspergillosis in Japan caused by <italic>A.
fischeri</italic>. The isolate from this case was susceptible to ITZ, VRZ and MCF, but was
resistant to AMB. Therefore, the cat was administered ITZ orally for 12 days, and it died on
day 19. The poor response in this case may have reflected progression of the infection. A
rapid diagnosis method and effective treatment are needed based on speciation and antifungal
susceptibility testing of infecting agents.</p>
  </body>
  <back>
    <ack>
      <p>This study was supported by a grant (&#x201C;International joint research and
training of young researchers for zoonosis control in the globalized world&#x201D;) from the
Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan, and by a Nihon
University Multidisciplinary Research Grant (2013&#x2013;2014). We thank to Chieko
Ishikawa<sup>2)</sup> who took CT scan.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Balajee</surname><given-names>S. A.</given-names></name><name><surname>Marr</surname><given-names>K. A.</given-names></name></person-group><year>2006</year>. <article-title>Phenotypic and genotypic identification
of human pathogenic aspergilli</article-title>. <source><italic>Future
Microbiol.</italic></source><volume>1</volume>: <fpage>435</fpage>&#x2013;<lpage>445</lpage>.
doi: <pub-id pub-id-type="doi">10.2217/17460913.1.4.435</pub-id><pub-id pub-id-type="pmid">17661634</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Balajee</surname><given-names>S. A.</given-names></name><name><surname>Tay</surname><given-names>S. T.</given-names></name><name><surname>Lasker</surname><given-names>B. A.</given-names></name><name><surname>Hurst</surname><given-names>S. F.</given-names></name><name><surname>Rooney</surname><given-names>A. P.</given-names></name></person-group><year>2007</year>. <article-title>Characterization of a novel gene for
strain typing reveals substructuring of <italic>Aspergillus fumigatus</italic> across
North America</article-title>. <source><italic>Eukaryot.
Cell</italic></source><volume>6</volume>: <fpage>1392</fpage>&#x2013;<lpage>1399</lpage>. doi:
<pub-id pub-id-type="doi">10.1128/EC.00164-07</pub-id><pub-id pub-id-type="pmid">17557880</pub-id></mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Barachetti</surname><given-names>L.</given-names></name><name><surname>Mortellaro</surname><given-names>C. M.</given-names></name><name><surname>Di Giancamillo</surname><given-names>M.</given-names></name><name><surname>Giudice</surname><given-names>C.</given-names></name><name><surname>Martino</surname><given-names>P.</given-names></name><name><surname>Travetti</surname><given-names>O.</given-names></name><name><surname>Miller</surname><given-names>P. E.</given-names></name></person-group><year>2009</year>. <article-title>Bilateral orbital and nasal aspergillosis
in a cat</article-title>. <source><italic>Vet.
Ophthalmol.</italic></source><volume>12</volume>: <fpage>176</fpage>&#x2013;<lpage>182</lpage>.
doi: <pub-id pub-id-type="doi">10.1111/j.1463-5224.2009.00695.x</pub-id><pub-id pub-id-type="pmid">19392877</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Barrs</surname><given-names>V. R.</given-names></name><name><surname>Halliday</surname><given-names>C.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name><name><surname>Wilson</surname><given-names>B.</given-names></name><name><surname>Krockenberger</surname><given-names>M.</given-names></name><name><surname>Gunew</surname><given-names>M.</given-names></name><name><surname>Bennett</surname><given-names>S.</given-names></name><name><surname>Koehlmeyer</surname><given-names>E.</given-names></name><name><surname>Thompson</surname><given-names>A.</given-names></name><name><surname>Fliegner</surname><given-names>R.</given-names></name><name><surname>Hocking</surname><given-names>A.</given-names></name><name><surname>Sleiman</surname><given-names>S.</given-names></name><name><surname>O&#x2019;Brien</surname><given-names>C.</given-names></name><name><surname>Beatty</surname><given-names>J. A.</given-names></name></person-group><year>2012</year>. <article-title>Sinonasal and sino-orbital aspergillosis
in 23 cats: aetiology, clinicopathological features and treatment
outcomes</article-title>. <source><italic>Vet. J.</italic></source><volume>191</volume>:
<fpage>58</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tvjl.2011.02.009</pub-id><pub-id pub-id-type="pmid">21388842</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Barrs</surname><given-names>V. R.</given-names></name><name><surname>Talbot</surname><given-names>J. J.</given-names></name></person-group><year>2014</year>. <article-title>Feline aspergillosis</article-title>.
<source><italic>Vet. Clin. North Am. Small Anim.
Pract.</italic></source><volume>44</volume>: <fpage>51</fpage>&#x2013;<lpage>73</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.cvsm.2013.08.001</pub-id><pub-id pub-id-type="pmid">24268333</pub-id></mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Cant&#xF3;n</surname><given-names>E.</given-names></name><name><surname>Espinel-Ingroff</surname><given-names>A.</given-names></name><name><surname>Pem&#xE1;n</surname><given-names>J.</given-names></name></person-group><year>2009</year>. <article-title>Trends in antifungal susceptibility
testing using CLSI reference and commercial methods</article-title>.
<source><italic>Expert Rev. Anti Infect. Ther.</italic></source><volume>7</volume>:
<fpage>107</fpage>&#x2013;<lpage>119</lpage>. doi: <pub-id pub-id-type="doi">10.1586/14787210.7.1.107</pub-id><pub-id pub-id-type="pmid">19622060</pub-id></mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Giordano</surname><given-names>C.</given-names></name><name><surname>Gianella</surname><given-names>P.</given-names></name><name><surname>Bo</surname><given-names>S.</given-names></name><name><surname>Vercelli</surname><given-names>A.</given-names></name><name><surname>Giudice</surname><given-names>C.</given-names></name><name><surname>Della Santa</surname><given-names>D.</given-names></name><name><surname>Tortorano</surname><given-names>A. M.</given-names></name><name><surname>Peruccio</surname><given-names>C.</given-names></name><name><surname>Peano</surname><given-names>A.</given-names></name></person-group><year>2010</year>. <article-title>Invasive mould infections of the
naso-orbital region of cats: a case involving <italic>Aspergillus fumigatus</italic> and
an aetiological review</article-title>. <source><italic>J. Feline Med.
Surg.</italic></source><volume>12</volume>: <fpage>714</fpage>&#x2013;<lpage>723</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.jfms.2010.07.015</pub-id><pub-id pub-id-type="pmid">20800212</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kano</surname><given-names>R.</given-names></name><name><surname>Itamoto</surname><given-names>K.</given-names></name><name><surname>Okuda</surname><given-names>M.</given-names></name><name><surname>Inokuma</surname><given-names>H.</given-names></name><name><surname>Hasegawa</surname><given-names>A.</given-names></name><name><surname>Balajee</surname><given-names>S. A.</given-names></name></person-group><year>2008</year>. <article-title>Isolation of <italic>Aspergillus
udagawa</italic>e from a fatal case of feline orbital aspergillosis</article-title>.
<source><italic>Mycoses</italic></source><volume>51</volume>:
<fpage>360</fpage>&#x2013;<lpage>361</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1439-0507.2008.01493.x</pub-id><pub-id pub-id-type="pmid">18855848</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kano</surname><given-names>R.</given-names></name><name><surname>Shibahashi</surname><given-names>A.</given-names></name><name><surname>Fujino</surname><given-names>Y.</given-names></name><name><surname>Sakai</surname><given-names>H.</given-names></name><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Tsujimoto</surname><given-names>H.</given-names></name><name><surname>Yanai</surname><given-names>T.</given-names></name><name><surname>Hasegawa</surname><given-names>A.</given-names></name></person-group><year>2013</year>. <article-title>Two cases of feline orbital aspergillosis
due to (<italic>Aspergillus udagawae</italic>) and (<italic>A.
viridinutans</italic>)</article-title>. <source><italic>J. Vet. Med.
Sci.</italic></source><volume>75</volume>: <fpage>7</fpage>&#x2013;<lpage>10</lpage>. doi:
<pub-id pub-id-type="doi">10.1292/jvms.12-0119</pub-id><pub-id pub-id-type="pmid">22878535</pub-id></mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Michael</surname><given-names>J. D.</given-names></name><name><surname>Vanessa</surname><given-names>R. D. B.</given-names></name></person-group><year>2012</year> Feline snionasal and sinoorbital <italic>Aspergillus
fumigatus</italic> complex and Penicillium infections. pp. 659&#x2013;662. <italic>In</italic>:
Infectious Diseases of Dog and Cat, 4th ed, (Green, C. E. ed.), Saunders Elsevier, St.
Louis.</mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Pfaller</surname><given-names>M. A.</given-names></name><name><surname>Messer</surname><given-names>S. A.</given-names></name><name><surname>Boyken</surname><given-names>L.</given-names></name><name><surname>Hollis</surname><given-names>R. J.</given-names></name><name><surname>Diekema</surname><given-names>D. J.</given-names></name></person-group><year>2003</year>. <article-title><italic>In vitro</italic> susceptibility
testing of filamentous fungi: comparison of Etest and reference M38-A microdilution
methods for determining posaconazole MICs</article-title>. <source><italic>Diagn.
Microbiol. Infect. Dis.</italic></source><volume>45</volume>:
<fpage>241</fpage>&#x2013;<lpage>244</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0732-8893(02)00544-8</pub-id><pub-id pub-id-type="pmid">12729993</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Whitney</surname><given-names>J.</given-names></name><name><surname>Beatty</surname><given-names>J. A.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name><name><surname>Dhand</surname><given-names>N. K.</given-names></name><name><surname>Briscoe</surname><given-names>K.</given-names></name><name><surname>Barrs</surname><given-names>V. R.</given-names></name></person-group><year>2013</year>. <article-title>Evaluation of serum galactomannan
detection for diagnosis of feline upper respiratory tract aspergillosis</article-title>.
<source><italic>Vet. Microbiol.</italic></source><volume>162</volume>:
<fpage>180</fpage>&#x2013;<lpage>185</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2012.09.002</pub-id><pub-id pub-id-type="pmid">23031342</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
